Recent pharmacological advances in the management of gout

被引：14
作者：
Davies, Kristen [1 ]
Bukhari, Marwan A. S. [1 ,2 ]
机构：
[1] Univ Lancaster, Fac Hlth & Med, Lancaster, England
[2] Univ Hosp Morecambe Bay NHS Fdn Trust, Royal Lancaster Infirm, Dept Rheumatol, Lancaster, England
来源：
RHEUMATOLOGY | 2018年 / 57卷 / 06期
关键词：
gout; management; EULAR; IL-1; allopurinol; canakinumab; anakinra; febuxostat; pharmacology; lesinurad; DOUBLE-BLIND; TOPHACEOUS GOUT; URIC-ACID; LOWERING THERAPY; COST-EFFECTIVENESS; FLARE PREVENTION; RENAL-FUNCTION; PHASE-III; ALLOPURINOL; FEBUXOSTAT;
D O I：
10.1093/rheumatology/kex343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gout is the most common cause of inflammatory arthritis worldwide, and reports show that despite availability of therapies, management is still suboptimal. The new EULAR 2016 recommendations for the treatment of gout highlight the huge development in gout therapies, and the number of drugs being trialled only continues to increase. A clinical review of the evidence that underlies the recommendations from EULAR can reveal possible gaps in the literature and avenues for future research into gout therapies.
引用
收藏
页码：951 / 958
页数：8
相关论文
共 75 条
  • [1] Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases
    Avram, Annalina
    Duarte, Catia
    Santos, Maria Jose
    Papagoras, Charalampos
    Ritis, Konstantinos
    Scarpioni, Roberto
    Schmidt, Wolfgang A.
    Skendros, Panagiotis
    [J]. JOINT BONE SPINE, 2015, 82 : ES17 - ES29
  • [2] Inhibiting the Inflammasome: A Chemical Perspective
    Baldwin, Alex G.
    Brough, David
    Freeman, Sally
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 1691 - 1710
  • [3] Resolution of gouty tophi after twelve weeks of pegloticase treatment
    Baraf, Herbert S. B.
    Matsumoto, Alan K.
    Maroli, Allan N.
    Waltrip, Royce W., II
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3632 - 3634
  • [4] Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
    Baraf, Herbert S. B.
    Yood, Robert A.
    Ottery, Faith D.
    Sundy, John S.
    Becker, Michael A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 427 - 432
  • [5] Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
    Baraf, Herbert S. B.
    Becker, Michael A.
    Gutierrez-Urena, Sergio R.
    Treadwell, Edward L.
    Vazquez-Mellado, Janitzia
    Rehrig, Claudia D.
    Ottery, Faith D.
    Sundy, John S.
    Yood, Robert A.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [6] Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
    Bardin, Thomas
    Keenan, Robert T.
    Khanna, Puja P.
    Kopicko, Jeff
    Fung, Maple
    Bhakta, Nihar
    Adler, Scott
    Storgard, Chris
    Baumgartner, Scott
    So, Alexander
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (05) : 811 - 820
  • [7] Cost-effectiveness of febuxostat in chronic gout
    Beard, Stephen M.
    von Scheele, Birgitta G.
    Nuki, George
    Pearson, Isobel V.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (05) : 453 - 463
  • [8] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    Becker, MA
    Schumacher, HR
    Wortmann, RL
    MacDonald, PA
    Eustace, D
    Palo, WA
    Streit, J
    Joseph-Ridge, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2450 - 2461
  • [9] The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
    Becker, Michael A.
    Schumacher, H. Ralph
    Espinoza, Luis R.
    Wells, Alvin F.
    MacDonald, Patricia
    Lloyd, Eric
    Lademacher, Christopher
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [10] Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
    Becker, Michael A.
    Schumacher, H. Ralph
    MacDonald, Patricia A.
    Lloyd, Eric
    Lademacher, Christopher
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1273 - 1282
12345678